sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastiske midler - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
aripiprazole "aristo" 5 mg tabletter
aristo pharma gmbh - aripiprazol - tabletter - 5 mg
cisplatin "pfizer" 1 mg/ml koncentrat til infusionsvæske, opløsning
pfizer aps - cisplatin - koncentrat til infusionsvæske, opløsning - 1 mg/ml
duloxetine "medical valley" 60 mg enterokapsler, hårde
medical valley invest ab - duloxetinhydrochlorid - enterokapsler, hårde - 60 mg
leponex 25 mg tabletter
viatris aps - clozapin - tabletter - 25 mg
rizatriptan "mylan" 10 mg smeltetabletter
mylan ab - rizatriptanbenzoat - smeltetabletter - 10 mg
rizatriptan "teva" 10 mg smeltetabletter
teva b.v. - rizatriptanbenzoat - smeltetabletter - 10 mg
ropivacaine "bioq" 2 mg/ml infusionsvæske, opløsning i administrationssystem
bioq pharma b.v. - ropivacainhydrochloridmonohydrat - infusionsvæske, opløsning i administrationssystem - 2 mg/ml
sertralin "accord" 50 mg filmovertrukne tabletter
accord healthcare b.v. - sertralinhydrochlorid - filmovertrukne tabletter - 50 mg
sertralin "teva" 50 mg filmovertrukne tabletter
teva b.v. - sertralinhydrochlorid - filmovertrukne tabletter - 50 mg